Portfolio

The Digitalis Commons portfolio reflects a focused approach to developing biomedical technologies that serve the public interest.

We prioritize opportunities where scientific promise intersects with unmet need and clear gaps in market-driven development—areas where meaningful impact is possible, but unlikely to emerge through conventional pathways.

Across the portfolio, we advance technologies that address neglected conditions, enable broader innovation, or translate publicly funded research into accessible solutions.

Building a comprehensive longitudinal dataset capturing women’s lived experiences to transform women’s health from a field of fragmented, cross-sectional snapshots into one with true understanding of disease and health history.

Digitalis Commons supported the launch of DiMe, a leading nonprofit advancing digital medicine to optimize health.

Digitalis Commons develops technologies in close collaboration with academic institutions, nonprofits, and industry partners. We act as an active development partner, helping to shape strategy, coordinate execution, and advance programs through key inflection points.